Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
ANTI-PNAG MONOCLONAL ANTIBODY
Not marketed
Infection prophylaxis
PKD11791NANCT01389700Summary
ANTI-TGFb MONOCLONAL ANTIBODY
Not marketed
Malignant solid tumor
TCD14678NANCT03192345Publication
ANTI-THYMOCYTE GLOBULIN (RABBIT)
Thymoglobulin
kidney transplant rejection
SANG-93-3-K-THY-R*NASummary
ANTI-THYMOCYTE GLOBULIN (RABBIT)
Thymoglobulin
kidney transplant rejection
SANG-96-3-K-THY-I*NASummary
ANTI-THYMOCYTE GLOBULIN (RABBIT)
Thymoglobulin
kidney transplant rejection
SMC-101-1002*NASummary
ANTI-THYMOCYTE GLOBULIN (RABBIT)
Thymoglobulin
kidney transplant rejection
SMC-101-1007*NASummary
ANTI-THYMOCYTE GLOBULIN (RABBIT)
Thymoglobulin
kidney transplant rejection
SMC-101-1008*NASummary
ANTI-THYMOCYTE GLOBULIN (RABBIT)
Thymoglobulin
kidney transplant rejection
SMC-101-1009*NASummary
ANTI-THYMOCYTE GLOBULIN (RABBIT)
Thymoglobulin
kidney transplant rejection
SMC-534-1003*NASummary
ANTIBODY DRUG CONJUGATE
Not marketed
Neoplasm Malignant
TED14147NANCT02575781Summary

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted